Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;178(4):1448-52.
doi: 10.1016/j.ajpath.2010.12.018. Epub 2011 Mar 4.

Helicobacter pylori induction of eosinophil migration is mediated by the cag pathogenicity island via microbial-epithelial interactions

Affiliations

Helicobacter pylori induction of eosinophil migration is mediated by the cag pathogenicity island via microbial-epithelial interactions

Toni A Nagy et al. Am J Pathol. 2011 Apr.

Abstract

The host immune response directed against Helicobacter pylori is ineffective in eliminating the organism and strains harboring the cag pathogenicity island augment disease risk. Because eosinophils are a prominent component of H. pylori-induced gastritis, we investigated microbial and host mechanisms through which H. pylori regulates eosinophil migration. Our results indicate that H. pylori increases production of the chemokines CCL2, CCL5, and granulocyte-macrophage colony-stimulating factor by gastric epithelial cells and that these molecules induce eosinophil migration. These events are mediated by the cag pathogenicity island and by mitogen-activated protein kinases, suggesting that eosinophil migration orchestrated by H. pylori is regulated by a virulence-related locus.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Co-culture of H. pylori with gastric epithelial cells induces eosinophil migration and chemokine production. A: Eosinophil migration toward supernatants harvested from MKN28 cells cultured alone or in the presence of wild-type H. pylori strain 60190. Bars represent the mean ± SEM of 7 experiments. *P < 0.003 vs control. B: Eosinophil migration toward supernatants harvested from MKN28 cells cultured alone (control) or in the presence of wild-type H. pylori strain 60190, isogenic cagA, cagL, slt, or vacA mutants, or heat-killed H. pylori. Bars represent the mean ± SEM of 5 experiments. *P < 0.05 versus 60190.
Figure 2
Figure 2
Chemokines induced by H. pylori infection of gastric epithelial cells mediate eosinophil migration. A: Chemokine concentrations in the supernatants of MKN28 cells cultured alone or in the presence of H. pylori strain 60190. Bars represent the mean ± SEM of 5 experiments. *P = 0.013, 0.047, 0.0002, and 0.021 for CCL2, CCL3, CCL5, and GM-CSF, respectively, versus uninfected controls. B: Chemokine concentrations in the supernatants of MKN28 cells cultured alone or in the presence of H. pylori wild-type strain 60190 or isogenic cagA, cagL, slt, or vacA mutants. Bars represent the mean ± SEM of 5 experiments. *P < 0.05 vs CCL2 control. **P < 0.05 vs CCL5 control. ***P < 0.05 vs GM-CSF control. C: Eosinophil migration toward media alone or increasing concentrations of the chemokines CCL11 (positive control), GM-CSF, CCL5, CCL2, or CCL3.
Figure 3
Figure 3
Effect of MAPK inhibition on H. pylori–induced eosinophil migration and gastric epithelial cell chemokine expression. A: Eosinophil migration toward supernatants harvested from MKN28 cells cultured alone or in the presence of wild-type H. pylori strain 60190 with or without SB203580 (p38i), PD98059 (ERKi), or JNK inhibitor II (JNKi). Bars represent the mean ± SEM of 5 experiments. *P < 0.05 versus 60190 in the presence of vehicle (dimethyl sulfoxide) alone. B: Chemokine expression in cell lysates harvested from MKN28 cells cultured alone or in the presence of H. pylori strain 60190 with or without SB203580 (p38i) and PD98059 (ERKi) as assessed by real-time RT-PCR. Bars represent the mean ± SEM of 5 experiments. *P = 0.0109 versus 60190 in the presence of vehicle (dimethyl sulfoxide) alone.

References

    1. Peek R.M., Jr, Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Rev Cancer. 2002;2:28–37. - PubMed
    1. Kwok T., Zabler D., Urman S., Rohde M., Hartig R., Wessler S., Misselwitz R., Berger J., Sewald N., Konig W., Backert S. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature. 2007;449:862–866. - PubMed
    1. Viala J., Chaput C., Boneca I.G., Cardona A., Girardin S.E., Moran A.P., Athman R., Memet S., Huerre M.R., Coyle A.J., DiStefano P.S., Sansonetti P.J., Labigne A., Bertin J., Philpott D.J., Ferrero R.L. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004;5:1166–1174. - PubMed
    1. Allison C.C., Kufer T.A., Kremmer E., Kaparakis M., Ferrero R.L. Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. J Immunol. 2009;183:8099–8109. - PubMed
    1. Watanabe T.A.N., Fichtner-Feigl S., Gorelick P.L., Tsuji Y., Matsumoto Y., Chiba T., Fuss I.J., Kitani A., Strober W. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J Clin Invest. 2010;120:1645–1662. - PMC - PubMed